European value strategy review for a surgical device
Combining gap and landscape analysis with payer research to optimise market access
Our client required a rapid, strategic market access review to support a recently acquired medical device. The device was already in use in the US and the review was to assess the market access opportunities and any value barriers in key European countries.
A number of studies had reported the effects of the device in key surgical areas. The client needed to prioritise the opportunities – stratified by market and indication – from market access and reimbursement perspectives.
We conducted two research phases:
- A critical, rapid review and interpretation of the evidence, covering the clinical effectiveness and economic value. To expedite the process we conducted a first pass ‘review of reviews’ to synthesise the evidence rapidly and identify top line strengths and weaknesses.
- Interviews with clinical and economic stakeholders in the target markets to evaluate possible routes for market access and potential barriers and opportunities for reimbursement.
The research defined an unmet need across the indications, and identified the extent to which the new technology addressed those needs as well as evidence gaps. For each indication we provided country-specific recommendations for clinical and economic evidence, reimbursement potential and market size.
Value to the client
The client had a clear course of action for commissioning new studies with a rationale for market prioritisation.